Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive third-quarter results

4

By Mariam Sunny and Christy Santhosh Nov 3 (Reuters) – Pfizer raised its full-year profit and revenue forecasts on Tuesday as strong demand for its recently acquired cancer drug Padcev and blockbuster

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)